Clearmind Medicine Inc.
CMNDNASDAQHealthcare● Active
$3.79
$-0.19(-4.77%)
Market Cap$3862135
P/E Ratio—
52W High$524
52W Low$2.1
Clearmind Medicine Inc. (CMND) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CMND · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 12, 2026EPS Actual
-$3.32
Revenue
—
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 12, 2026
After Market Close
CMND reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q1 FY2026 | Mar 12, 2026 | — | -$3.32 | — | — | — | — |
| — Q1 FY2026 | Jan 28, 2026 | — | -$4.40 | — | — | — | — |
| — Q3 FY2025 | Sep 11, 2025 | — | -$10.00 | — | — | — | — |
| — Q2 FY2025 | Jun 12, 2025 | — | -$6.40 | — | — | — | — |
| — Q1 FY2025 | Mar 13, 2025 | — | -$9.60 | — | — | — | — |
| — Q1 FY2025 | Jan 22, 2025 | — | -$0.11 | — | — | — | — |
| — Q3 FY2024 | Sep 16, 2024 | — | -$0.59 | — | — | — | — |
| — Q2 FY2024 | Jun 13, 2024 | — | -$0.28 | — | — | — | — |
Q1 FY2026
Mar 12, 2026
EPS Actual
-$3.32
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Jan 28, 2026
EPS Actual
-$4.40
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Sep 11, 2025
EPS Actual
-$10.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
Jun 12, 2025
EPS Actual
-$6.40
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 13, 2025
EPS Actual
-$9.60
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Jan 22, 2025
EPS Actual
-$0.11
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Sep 16, 2024
EPS Actual
-$0.59
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
Jun 13, 2024
EPS Actual
-$0.28
EPS Est.
—
EPS Surpr.
—
Revenue
—
No analyst estimates available for CMND.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Mar 12, 2026 | — | $9.37 | $8.29 | -11.53% |
| — Q1 FY2026 | Jan 28, 2026 | — | $26.80 | $25.20 | -5.97% |
| — Q3 FY2025 | Sep 11, 2025 | — | $408.00 | $420.00 | +2.94% |
| — Q2 FY2025 | Jun 12, 2025 | — | $356.20 | $342.50 | -3.85% |
| — Q1 FY2025 | Mar 13, 2025 | — | $452.00 | $452.00 | +0.00% |
| — Q1 FY2025 | Jan 22, 2025 | — | $576.00 | $580.00 | +0.69% |
| — Q3 FY2024 | Sep 16, 2024 | — | $536.00 | $532.00 | -0.75% |
| — Q2 FY2024 | Jun 13, 2024 | — | $436.00 | $432.00 | -0.92% |
Q1 FY2026-11.53%
Report Date
Mar 12, 2026
EPS Beat/Miss
—
Price Before
$9.37
Price After
$8.29
Q1 FY2026-5.97%
Report Date
Jan 28, 2026
EPS Beat/Miss
—
Price Before
$26.80
Price After
$25.20
Q3 FY2025+2.94%
Report Date
Sep 11, 2025
EPS Beat/Miss
—
Price Before
$408.00
Price After
$420.00
Q2 FY2025-3.85%
Report Date
Jun 12, 2025
EPS Beat/Miss
—
Price Before
$356.20
Price After
$342.50
Q1 FY2025+0.00%
Report Date
Mar 13, 2025
EPS Beat/Miss
—
Price Before
$452.00
Price After
$452.00
Q1 FY2025+0.69%
Report Date
Jan 22, 2025
EPS Beat/Miss
—
Price Before
$576.00
Price After
$580.00
Q3 FY2024-0.75%
Report Date
Sep 16, 2024
EPS Beat/Miss
—
Price Before
$536.00
Price After
$532.00
Q2 FY2024-0.92%
Report Date
Jun 13, 2024
EPS Beat/Miss
—
Price Before
$436.00
Price After
$432.00
Beat Rate0 / 8 quarters
Largest Move-11.53% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CMND ends December
Clearmind Medicine Inc. (CMND) most recently reported earnings on March 12, 2026 for Q1 FY2026, posting EPS of $-3.32 (in line with the analyst consensus of —). The next CMND earnings date is expected around September 1, 2026.
Each quarter, investors track CMND earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CMND revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CMND's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CMND earnings · 4 questionsClearmind Medicine Inc.'s next earnings report is expected around September 1, 2026. CMND typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CMND historically reports after market close (AMC).
CMND earnings datewhen is CMND earningsCMND next earnings datewhen does CMND report earningsCMND earnings calendar
▸ Source: FMP · Clearmind Medicine Inc. SEC filings · US GAAP · Clearmind Medicine Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026